IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,000 | 0.0% | 667 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $3,000 | 0.0% | 667 | 0.0% | 0.00% | – |
Q1 2022 | $3,000 | -40.0% | 667 | -3.5% | 0.00% | -100.0% |
Q4 2021 | $5,000 | +25.0% | 691 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $4,000 | -20.0% | 691 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $5,000 | -16.7% | 691 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $6,000 | +50.0% | 691 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $4,000 | +100.0% | 691 | 0.0% | 0.00% | – |
Q3 2020 | $2,000 | -33.3% | 691 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $3,000 | +50.0% | 691 | -4.3% | 0.00% | – |
Q1 2020 | $2,000 | -50.0% | 722 | 0.0% | 0.00% | -100.0% |
Q4 2019 | $4,000 | +100.0% | 722 | -0.1% | 0.00% | – |
Q3 2019 | $2,000 | 0.0% | 723 | +2.4% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 706 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | -33.3% | 706 | 0.0% | 0.00% | -100.0% |
Q4 2018 | $3,000 | -57.1% | 706 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $7,000 | 0.0% | 706 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $7,000 | 0.0% | 706 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $7,000 | – | 706 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |